The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2024 and forecasted to 2033

According to The Business Research Company’s Glycomic Therapeutics Global Market Report 2024, the glycomic therapeutics market is expected to show promising growth in the forecast period.

Introduction

• The glycomic therapeutics market has witnessed rapid growth in recent years.
• Projections indicate a continued upward trend, with substantial expansion expected.

Current Market Landscape

• The market size surged from $141.31 billion in 2023 to $163.73 billion in 2024.
• Compound annual growth rate (CAGR) reached an impressive 15.9%.
• Factors driving historic growth include increased awareness of glycan significance and collaborations in glycomics research.

Future Growth Projections

• Anticipated growth to $301.03 billion by 2028.
• CAGR forecasted at 16.4%.
• Expansion attributed to advancing knowledge of glycan biology and rising interest in immunotherapy.

View More On The Glycomic Therapeutics Market Report 2024 – https://www.thebusinessresearchcompany.com/report/glycomic-therapeutics-global-market-report

Major Trends in Forecast Period

• Oncology applications witnessing significant expansion.
• Glycoengineering enhancing therapeutic proteins.
• Inclusion of glycomics in immuno-oncology and rare genetic disorders.
• Regulatory considerations for glycomic drugs.

Rising Diabetes Prevalence Fuels Market Growth

• Diabetes prevalence surge contributes to market expansion.
• Glycans play a crucial role in diabetes diagnosis and treatment monitoring.
• Notable increase in diagnosed diabetes cases observed, particularly in the United States.

Innovations Driving Market Advancements

• Product innovation emerges as a key trend.
• Companies prioritize technological advancements to strengthen market position.
• Example: Glenmark Pharmaceuticals’ launch of a novel fixed-dose combination for type 2 diabetes treatment.

Halozyme Therapeutics Expands Portfolio

• Acquisition of Antares Pharma Inc. for $960 million in May 2022.
• Augmentation of pipeline portfolio with superior drug delivery methods.
• Enhanced safety, efficacy, convenience, and patient adherence.

Segmentation of the Glycomic Therapeutics Market

• Class segmentation: Isolated, Synthetic.
• Structures segmentation: Glycoproteins, Proteoglycans, Glycosylphosphatidylinositol (GPI)-Anchored Proteins, etc.
• Mode of action segmentation: Inhibits Neuraminidase, Inhibits Heparanase, Erythropoietin and Enzyme Replacement Therapy (ERT), etc.
• Indications segmentation: Thrombosis, Anemia, Cancer, Alzheimer’s Disease, etc.

Regional Insights

• North America dominated the market in 2023.
• Asia-Pacific poised for rapid growth in the forecast period.

Conclusion

• The glycomic therapeutics market exhibits robust growth prospects, fueled by rising disease prevalence and technological innovations.
• Continued research and development efforts are essential to harness the full potential of glycomic therapeutics in addressing diverse medical needs globally.

Request A Sample Of The Global Glycomic Therapeutics Market Report 2024:
https://www.thebusinessresearchcompany.com/sample_request?id=11894&type=smp